Every material Form 8-K Central Garden & Pet filed with the SEC in 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Central Garden & Pet said John D. Walker will retire as President, Garden Consumer Products, effective September 26, 2026. The filing does not name a successor or describe the reasons for the retirement.
John D. Walker is retiring as President, Garden Consumer Products.
The retirement is effective September 26, 2026.
The company announced the change on September 21, 2026.
The filing does not name a successor or give financial figures.
Central Garden & Pet reported fiscal 2026 third-quarter net sales of $882 million, down 8% from $961 million, while organic net sales rose 2%. The company raised its fiscal 2026 non-GAAP diluted EPS outlook to $2.85 or better from $2.70 or better, and agreed after quarter-end to acquire an 80% interest in TRIXIE for €340 million in cash at closing plus up to €60 million in earn-out payments.
Q3 net sales were $882 million versus $961 million, down 8%; organic net sales rose 2% to $862 million versus $842 million.
Q3 GAAP diluted EPS was $1.45 versus $1.52; non-GAAP diluted EPS was $1.54 versus $1.56.
Fiscal 2026 non-GAAP diluted EPS outlook raised to $2.85 or better from $2.70 or better.
Agreed to acquire 80% of TRIXIE for €340 million in cash at closing plus up to €60 million in earn-out payments; closing is expected in the first half of fiscal 2027.
Central Garden & Pet reported fiscal 2026 second-quarter net sales of $906 million, up from $834 million a year earlier, and GAAP diluted EPS of $1.28, up from $0.98. The company reaffirmed its fiscal 2026 non-GAAP diluted EPS outlook of $2.70 or better and said it entered a pet distribution partnership with Phillips after the quarter, in which Central keeps a 20% stake. The results are preliminary until the company files its Form 10-Q.
Net sales $906 million vs. $834 million; operating income $114 million vs. $93 million.
GAAP diluted EPS $1.28 vs. $0.98; non-GAAP diluted EPS $1.29 vs. $1.04.
Fiscal 2026 non-GAAP diluted EPS outlook of $2.70 or better reaffirmed.
Central to retain a 20% stake in the new pet distribution business; Phillips and its investors hold 80%.
On February 11, 2026, Central Garden & Pet's board approved a $100 million increase in the company's share repurchase authorization, bringing the total to approximately $127 million as of that date. The same day, shareholders elected nine directors, ratified Deloitte & Touche LLP as auditor, and approved the advisory vote on executive pay. The filing also discloses the appointment of Kay M. Schwichtenberg to the board, effective March 1, 2026.
Board approved a $100 million increase to the share repurchase authorization on February 11, 2026; total authorization is approximately $127 million as of that date.
Company press release states management considers the market price of its shares to be currently undervalued.
Kay M. Schwichtenberg appointed to the board effective March 1, 2026, and to the Audit Committee; she retired as Executive Vice President, Animal & Public Health in February 2023.
Shareholders approved the executive compensation advisory vote with 16,346,943 votes for and 218,084 against.
Central Garden & Pet reported fiscal 2026 first-quarter results with net sales of $617 million, down from $656 million, and GAAP diluted EPS of $0.11, down from $0.21. Non-GAAP diluted EPS was $0.21, flat with a year earlier, and the company reaffirmed its fiscal 2026 non-GAAP diluted EPS outlook of $2.70 or better. The company said the results are preliminary until it files its Form 10-Q, and the Garden segment swung to an operating loss.
Net sales were $617 million versus $656 million a year earlier, which management partly attributed to shipment timing and portfolio optimization.
GAAP diluted EPS was $0.11 versus $0.21; non-GAAP diluted EPS was $0.21, flat year over year.
Garden segment posted an operating loss of $10 million versus operating income of $2 million a year earlier.
Fiscal 2026 non-GAAP diluted EPS outlook of $2.70 or better was reaffirmed; the company has not yet filed its Form 10-Q for the quarter ended December 27, 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Central Garden & Pet filing is on SEC EDGAR ↗. 8-K briefs of other companies →